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Background: The activated leukocyte cell adhesion molecule (ALCAM) is involved in immune responses and cancer
metastasis.
Results: ALCAM is linked to the actin cytoskeleton through a supramolecular complex, including ezrin and syntenin-1.
Conclusion: ALCAM supramolecular complex engaged to CD6 stabilizes the immunological synapse.
Significance: Insights into the immunological synapse at the dendritic cell side contribute to clarify immune regulation
mechanisms.
Activated leukocyte cell adhesion molecule (ALCAM) is a
type I transmembrane protein member of the immunoglobulin
superfamily of cell adhesion molecules. Involved in important
pathophysiological processes such as the immune response,
cancer metastasis, and neuronal development, ALCAM under-
goes bothhomotypic interactionswith otherALCAMmolecules
and heterotypic interactions with the surface receptor CD6
expressed at the T cell surface. Despite biochemical and bio-
physical evidence of a dynamic association between ALCAM
and the actin cytoskeleton, no detailed information is available
about how this association occurs at the molecular level. Here,
we exploit a combination of complementary microscopy tech-
niques, including FRET detected by fluorescence lifetime imag-
ingmicroscopy and single-cell force spectroscopy, and we dem-
onstrate the existence of a preformed ligand-independent
supramolecular complex where ALCAM stably interacts with
actin by binding to syntenin-1 and ezrin. Interaction with the
ligand CD6 further enhances these multiple interactions. Alto-
gether, our results propose a novel biophysical framework to
understand the stabilizing role of the ALCAM supramolecular
complex engaged to CD6 during dendritic cell-T cell interac-
tions and provide novel information on the molecular players
involved in the formation and signaling of the immunological
synapse at the dendritic cell side.
The activated leukocyte cell adhesion molecule (ALCAM)12
is a type I transmembrane proteinmember of the immunoglob-
ulin superfamily of cell adhesion molecules initially identified
in activated leukocytes (1). Later studies have reportedALCAM
as being expressed also inmonocytes (2), bonemarrow stromal
cells (3), and hematopoietic supporting osteoblastic cells (4).
There is ample evidence in the literature revealing the involve-
ment of ALCAM-mediated interactions in several important
physiological processes such as maturation of hematopoietic
stem cells in blood forming tissues (3, 5, 6), neural development
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(7, 8), the immune response (1), and osteogenesis (9). Further-
more, ALCAM has been associated with the progression of
diverse types of cancer such as bladder cancer (10), breast can-
cer (11, 12), colorectal carcinoma (13), melanoma (14–16), and
more recently also glioblastoma (17).
ALCAM mediates homotypic ALCAM-ALCAM adhesion
(1, 18, 19) but heterotypic interactions with the T cell antigen
CD6 have also been described. In fact, ALCAM is the only
known ligand for CD6 identified on immune cells (1, 20) and
has been shown to localize at the immunological synapse (21) in
an antigen-dependent manner (22). More recently, ALCAM-
CD6 interactions have been reported to be involved in leuko-
cyte migration across the blood-brain barrier (23). We previ-
ously demonstrated that ALCAM-CD6 engagement plays a
pivotal role during early T cell-dendritic cell (DC) contact for-
mation and at later stages of T cell activation (24).
Intravital microscopy studies indicated that, within lymph-
oid tissue, naive T cells scan the surface of DCs at relative cell
speeds of up to 30 m/min (25). The ability to withstand shear
at the molecular level is therefore essential for establishing and
maintaining productive DC-T cell contacts for prolonged peri-
ods of time. These findings indicate a key role for both homo-
and heterotypic ALCAM-mediated adhesion during highly
dynamic cellular interactions occurring under different condi-
tions of external loading.
By using single-cell force spectroscopy (SCFS), we previously
demonstrated that homo- and heterotypic ALCAM-mediated
adhesion is governed by distinct kinetic and mechanical prop-
erties and that the ALCAM-CD6 bond is significantly more
stable under mechanical stress (26). More specifically,
ALCAM-CD6 interactions displayed higher tensile strengths
and a significantly smaller reactive compliance, suggesting that
this heterotypic bond is more resistant to applied force, and
hence more stable under conditions of mechanical stress than
the homotypic bond (26).
Interactions between plasma membrane components, sig-
naling molecules, and the actin cytoskeleton are important to
coordinate in time and space the signal transductionmachinery
leading to downstream activation events (27).Whereas numer-
ous studies have addressed the signal transduction events tak-
ing place at the T cell side of the immunological synapse, very
little is known about the biochemical events triggered at theDC
side. A sustained association between ALCAM and actin at the
DC side of the immunological synapse could play a role not only
in regulating the strength and duration of the cell-cell contact
but possibly also in regulating signal transduction into the DCs.
Despite biochemical and biophysical evidence of a dynamic
association between ALCAM and the actin cytoskeleton (18,
19, 26), no detailed information is available about how this asso-
ciation occurs at the molecular level.
The development of new fluorescent probes together with
recent advances in fluorescence microscopy deliver powerful
tools to study protein interactions in living cells at the molecu-
lar level. Fluorescence resonance energy transfer (FRET) is
widely used for quantifying protein-protein interactions in liv-
ing cells (28). Fluorescence lifetime imaging microscopy
(FLIM) serves as an appealing alternative to intensity-based
approaches to measure energy transfer. Fluorescence lifetime
measurements are independent of changes in excitation inten-
sity or fluorophore concentration. Moreover, spectral bleed
through rarely presents a problem in FLIM imaging. When the
acceptormolecules are inmolecular proximity of the donor (i.e.
5–10nm), energy transfer occurs, which leads to a decrease in
donor fluorescence lifetime. FRET-FLIM is therefore a power-
ful and well established method to visualize and quantify pro-
tein-protein interactions in living cells (29–32).
Interactions between transmembrane proteins like ALCAM
and the actin cytoskeleton are usually not direct but rather are
mediated by linker molecules that recognize, on the one hand,
conserved amino acid sequences present at the cytoplasmic tail
of the transmembrane proteins and, on the other hand, bear an
actin-binding domain (33). The short cytoplasmic tail of
ALCAM does not contain a direct binding site for actin. How-
ever, the cytoplasmic tail of ALCAM contains a cluster of pos-
itively charged amino acids that resembles known motifs rec-
ognized by actin-binding proteins of the ERM family, such as
ezrin, moesin, and radixin (34, 35). Moreover, the cytoplasmic
domain of ALCAM has a KTEA amino acid motif that repre-
sents a characteristic type I PDZ-binding motif (36). This short
sequence is known to be recognized by the PDZ domain con-
taining protein syntenin-1, which is also able to link transmem-
brane proteins to the cortical actin cytoskeleton (22, 37). It
remains to be determinedwhether these actin-binding proteins
interact with ALCAM.
In this study, we sought to determine the molecular mecha-
nisms regulating the interaction between ALCAM and the
actin cytoskeleton in relation to ALCAM’s function as a CD6-
binding receptor. By exploiting a combination of complemen-
tary microscopy techniques delivering quantitative biophysical
information such as FRET-FLIM and single-cell force spectros-
copy, we demonstrate the existence of a preformed supramo-
lecular complex where ALCAM stably interacts with actin by
binding to syntenin-1 and ezrin. This complex is further
strengthened upon ALCAM binding to the ligand CD6. Alto-
gether, our data propose a novel framework to understand the
stabilizing role of the ALCAM supramolecular complex
engaged to CD6 during DC-T cell interactions.
EXPERIMENTAL PROCEDURES
Materials—Monomeric red fluorescent protein (RFP) was a
gift ofDr.T.M. Jovin (MaxPlanck Institute forBiophysicalChem-
istry, Göttingen, Germany). The ALCAM-wild type (WT),
ALCAM-GFP, ALCAM-GPI, and ALCAM-Thr (T556A and
T581A) constructs were designed and described previously (18,
19). The chimeric ALCAM-RFP construct was generated by sub-
stitutinggreen fluorescentprotein (GFP)byRFP frompTagRFP-C
(Evrogen, Moscow, Russia) in the pEGFP-N3-ALCAM vector
(Clontech) using BamHI and NotI restriction sites. K562 cells
were transiently transfected by nucleoporation with an Amaxa
Nucleofector (Amaxa, Cologne, Germany) according to the
manufacturer’s instructions and were cultured for 24 h in
12-well plates prior to use. The plasmids for ezrin-GFP and
ezrin-RFP were obtained from Prof. S. Mayor, National Centre
for Biological Sciences, Bangalore, India (38). The plasmids for
syntenin-1-GFP and syntenin-1-mCherry were obtained from
Prof. P. Zimmermann, Department of Human Genetics, KU
Syntenin-1 and Ezrin Link ALCAM to the Actin Cytoskeleton
13446 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 19•MAY 9, 2014
 at RA
D
BO
U
D
 U
N
IV
ERSITEIT N
IJM
EG
EN
 on M
arch 6, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Leuven, Belgium. The pmTurquoise2-N1 (39) and mVenus
(L68V)-mTurquoise2 were a generous gift from Prof. T. W. J.
Gadella (Molecular Cytology, University of Amsterdam). The
pN1-mVenus plasmid was created by inserting the mVenus
sequence from mVenus (L68V)-mTurquoise2 into a pN1 vec-
tor using BglII and AgeI (Promega) restriction enzymes. This
vector was used in creating the human syntenin-1-mVenus
construct by introducing human syntenin-1 amplified from
hsyn1FL-eGFP (forward, 5-aaaaaacgagatctcgccaccatgtctctcta-
tccatctc-3, and reverse, 5-aaaaaaaaccggtggaacctcaggaatggtgt-
ggtcc-3) using BglII and AgeI (Promega). Ezrin-mVenus was
made by introducing ezrin excised from pHJ421 (Addgene
20680) into pN1-Venus using EcoRI and AgeI (Promega). The
ALCAM-mTurquoise2 plasmids were created by amplifying
both wild type and mutant with forward primer 5-aaaaaacgg-
aattcccgccaccatggaatccaagggggcc-3 and for ALCAM-WT
with reverse primer 5-aaaaaagggatccggggcttcagttttgtgatt-
gttttctt-3 and for ALCAM-Thr with reverse primer 5-aaaa-
aagggatccggggcttcagctttgtgattgttttctt-3. Both ALCAM-WT
andALCAM-Thrwere inserted into pmTurquoise2-N1using
EcoRI and BamHI (Promega). Plasmids amplification was car-
ried out by using an endotoxin-free maxi-kit fromQiagen (cat-
alog no. 12362) and a standardmaxi-kit from Promega (catalog
no. A2392). The actin cytoskeleton-disrupting drugs cytocha-
lasin D and latrunculin A were obtained from Invitrogen. Phal-
loidinwas purchased from Invitrogen; the anti-syntenin-1 anti-
body was a polyclonal rabbit anti-human poly-IgG (sc-48742),
and the anti-ezrin antibody was a polyclonal goat anti-human
poly-IgG (sc-6409), both from Santa Cruz Biotechnology, Inc.
The anti-GFP antibody was a mouse anti-GFP (IgG1) from
Pierce, and anti-ALCAM antibody was a mouse anti-human
monoclonal IgG2a antibody (clone AZN-L50).
Cell Culture and Transfection Assays—The K562 cell line
with stable expression of ALCAM-WT, ALCAM-GFP, or
ALCAM-Thr was cultured as described previously (19, 26).
K562 cells were grown in a mixture of 75% RPMI medium and
25% Iscove’s modified Dulbecco’s medium (Invitrogen) as
described previously (18), containing 10% FBS and 1% antibiot-
ics and antimycotics (Invitrogen), at 37 °C, with 5% CO2 in a
humidified atmosphere. The day before transfection, cells were
seeded in a 24-well plate at a density of 100,000 cells/well and
grown overnight. Transient transfections in K562 and RAW
264.7 cells were performed by using either of the following
transfection reagents FuGENE HD (Promega) or Lipo-
fectamine LTX (Invitrogen). The protocols were followed in
accordance with the manufacturer’s instructions, and the fluo-
rescence was measured 18–24 h post-transfection.
Substrate Coating—CD6-coated surfaces were prepared
using a three-step method as already reported (26). First, the
glass dishes were incubated for 1 h at 37 °C with 10 g/ml goat
anti-human Fc (Jackson ImmunoResearch,West Grove, PA) in
a buffer containing 20mMTris-HCl, 150mMNaCl, 1mMCaCl2,
2 mM MgCl2, pH 8.0 (TSM). After washing with TSM, the
uncovered glass surface was blocked with TSM containing 1%
bovine serum albumin (BSA), incubated for 30 min at 37 °C,
and again followed by washing with TSM. Finally, the glass
surface was incubated with 10 g/ml recombinant human
CD6-Fc (R&D systems, Minneapolis, MN) in TSM.
FLIM Experiments—Frequency domain FLIM experiments
on transfected K562 or RAW 264.7 cells were performed using
a Nikon TE2000-U inverted wide field microscope and a Lam-
bert Instruments fluorescence attachment (Lambert Instru-
ments, Roden, The Netherlands) for lifetime imaging (40). A
light-emitting diode (Lumiled LUXEON III, max  468 nm)
modulated at 40 MHz was used to excite GFP. Fluorescence
detection was performed by a combination of a modulated (40
MHz) image intensifier (II18MD; Lambert Instruments) and a
CCD camera (CCD-1300QD; VDS Vosskühler, Osnabrück,
Germany) with 640  512 pixels. The emission of GFP was
detected through a narrow emission filter (520/35 nm; Sem-
rock, Rochester, NY) to suppress any fluorescence emission
from RFP. Frequency domain FLIMmeasurements were refer-
enced to a 10 M solution of rhodamine 6G, the lifetime of
which was independently measured by time-correlated single
photon counting as 3.94 ns (data not shown). Fluorescence life-
times were calculated from several regions of interest and
defined to include multiple cells, and data are presented as his-
tograms. The fluorescence lifetime histograms were fitted to
Gaussian functions, fromwhich the centers of the distributions
and the distribution widths were extracted; the errors reported
are one-half of the distribution width. For acceptor photo-
bleaching measurements, a USH-102DH 100-watt mercury
lamp (Nikon) was used to illuminate the sample for about 5–10
min, yielding95% photobleaching. Images were recorded on
a cooled CCD camera (Coolsnap HQ, Roper Scientific). 470/
22-nm bandpass excitation filter, 495 nm long pass dichroic,
and 520/35 nm bandpass emission filters were used for GFP
imaging. 530/40-nm bandpass excitation filter, 562 nm long
pass dichroic, and 612/23 nm bandpass emission filters were
used for RFP photobleaching. Time domain FLIM was per-
formed using a confocal laser-scanningmicroscope (Zeiss LSM
510META installed on aZeiss Axiovert 200M;Carl Zeiss, Jena,
Germany). A pulsed Titanium:Sapphire laser (Mai Tai Deep
See, Spectra Physics, Newport Corp.) tuned at 820 nmwas used
for two-photon excitation. The excitation light was directed to
the sample through a water immersion objective (LD C-Apo-
chromat 40/1.1 W Korr UV-VIS-IR, Zeiss). The emission
light was separated from the excitation light using a 735-nm
dichroic beam splitter and further filtered using a short pass
735-nm filter, a dichroic beam splitter at FT490, and an
BP440–485-nm band pass filter. Finally, a GaAsP detector
(H7429-40, Hamamatsu) connected to a Becker and Hickl
SPC830 card (Becker and Hickl GmbH, Berlin, Germany) was
used to detect the emission light, allowing for time-correlated
single photon counting. The fluorescence lifetime images were
processed using SPCImage software from Becker and Hickl
using the incomplete exponentials model. The quality of the fit
was judged by the reduced 2 values. For the majority of the
pixels, the reduced 2 value was smaller than 1.2.
Confocal Microscopy Experiments—To determine co-local-
ization betweenALCAMand its interacting partners, cells were
either labeled with specific antibodies or transfected with fluo-
rescently tagged proteins. For co-capping experiments, we
treated the cells as already reported (41). Briefly, K562 cells
expressing the different ALCAM constructs were stained at
4 °C with 10 g/ml anti-ALCAMmAb AZN-L50. Isotype-spe-
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cific controls were always included. Patching was induced by
incubation at 12 °C for 1 h, followed by fixation with 2% para-
formaldehyde. Subsequently, cells were intracellularly stained
by phalloidin-Alexa546 for actin, rabbit poly-IgG anti-syn-
tenin-1 (sc-48742; Santa Cruz Biotechnology), or goat poly-IgG
anti-ezrin (sc-6409; Santa Cruz Biotechnology) using 5-min
0.1% Triton in PBS prior to labeling. Cells were mounted onto
poly-L-lysine-coated glass coverslips. Cells were analyzed by a
Leica confocal laser scanning microscope TCS SP5 II (Leica,
Mannheim, Germany) using sequential signal collection to avoid
bleed through. Co-localization of ALCAMwith actin, syntenin-1,
or ezrin was determined by calculating the Manders’ correlation
coefficientsM1 (0 no co-localization and 1 100% co-localiza-
tion) with the ImageJ (rsb.info.nih.gov) plug-in JACoP (42).
Co-immunoprecipitation Experiments—K562 cells were
transfected with a Neon transfection system (Invitrogen)
according to the manufacturer’s instructions. Briefly, K562-
ALCAM cells were transfected at a ratio of 3 g of DNA of the
reporter construct syntenin-1-GFP to 1  107 cells. Trans-
fected K562 cells were lysed in Tris/Triton lysis buffer (10 mM
Tris-HCl, pH 7.4, 100mMNaCl, 1%Triton X-100, 1mMEDTA,
1 mM EGTA, 10% glycerol, 0.1% SDS, 0.5% sodium deoxy-
cholate) containing EDTA-free protease inhibitor and PhosS-
TOP (RocheApplied Science). Proteinswere separated by SDS-
PAGE and transferred to PVDF membranes (Millipore).
Subsequently, blots were labeled by mouse anti-ALCAM, rabbit
anti-syntenin-1, goat anti-ezrin, or mouse anti-GFP, and scanned
by an Odyssey imager (LI-COR Biosciences). Secondary antibod-
ies (LI-COR) used for the immunoblot are as follows: goat anti-
rabbit IRDye800 (for syntenin-1); donkey anti-goat IRDye800 (for
ezrin); goat anti-mouse IRDye680 (forALCAMonsyntenin-1WB
and for GFP); and donkey anti-mouse IRDye680 (for ALCAM on
ezrinWB).ALCAMwas enriched from the post-nuclear superna-
tant (PNS) pre-cleared by protein G-Sepharose 4 Fast Flow beads
(GE Healthcare) coated with isotype antibody (IgG2a) and subse-
quent immunoprecipitation using beads coated with anti-AL-
CAM (AZN-L50).
AFM-SCFS Measurements—Cells were attached to tipless
AFM cantilevers (MLCT-O10, Bruker, Santa Barbara, CA) by
concanavalin A (ConA)-mediated linkages as described (26, 43,
44). In short, ConA-coated cantilevers were prepared as fol-
lows.Cantileverswere first cleaned by immersion in 1M sulfuric
acid (Sigma) for 1 h, then thoroughly rinsedwithMilli-Qwater,
ethanol, and subsequently dried in a N2 flow. Following an
overnight incubation at 4 °C in biotinylated BSA (biotin-BSA,
0.5 mg/ml in 100 mM NaHCO3, pH 8.6) the cantilevers were
rinsed using PBS and exposed to 0.5mg/ml (PBS, 30min, 37 °C)
streptavidin (Pierce). Finally, the cantilevers were rinsed three
times with TSM and incubated in biotinylated ConA (biotin-
ConA, 0.4 mg/ml in TSM) for 30 min at 37 °C and washed with
TSM. Force measurements on living cells were performed in
force-distancemode using a combined BioScope Catalyst AFM
(Bruker) mounted on a Leica TCS SP5 II confocal microscope.
Cantilever deflection was determined from the difference in
signal generated by a two-segment photodiode monitoring the
reflection of a laser beam focused onto the apex of the cantile-
ver. The spring constant of each cantilever was calibrated
before use by a nondestructive thermal oscillationmethod (45).
For AFM cell adhesion measurements (n  7 cells), a cell was
first adhered to the cantilever. The cantilever was pushed softly
(3 nN) onto the cell for10 s, and upon retraction, a positive
pickup was directly observed by the microscope. From that
moment, the cell was allowed to adhere strongly to the can-
tilever for at least 10 min. Adhesion of the cantilever-ad-
hered cell to CD6-Fc-coated glass substrates (50-mm glass
bottom Petri dishes, WillCo Wells BV, Amsterdam, The
Netherlands) was subsequently measured by bringing the
cell into contact with the substrate with a contact force of 1
nN and allowing the cell to adhere for 2 s. Subsequently, the
cell was retracted at a retraction speed at 12 m/s, with
subsequently a relaxing time of 10 s to give the cell time to
recover (43). Cell adhesion experiments were performed in a
perfusion chamber at 37 °C. Data were exported from the
BioScope Catalyst by the NanoScope Version 8.1 software
and further analyzed inMATLAB. Analysis of force-distance
curves resulted in the maximum detachment force Fmax of
every curve.
RESULTS
Analysis of ALCAM Interaction with the Actin Cytoskeleton
by Fluorescence Lifetime Imaging Microscopy—Previous work
from our laboratories demonstrated a role for the actin cyto-
skeleton in ALCAM-mediated adhesion by using both bio-
physical and biochemical approaches (18, 26). To confirm
this interaction by FLIM, we used K562 cells stably express-
ing ALCAM-GFP and transfected with RFP-tagged actin.
Inspection by confocal microscopy showed good expression
levels of plasma membrane localized ALCAM and intracel-
lular actin and confirmed their co-localization already prior
to engagement of ALCAM with its ligand (Fig. 1A). Subse-
quently, K562 cells co-expressing ALCAM-GFP and actin-
RFP were subjected to FRET-FLIM analysis (Fig. 1, B and C).
The lifetimes of the donor (GFP) for several individual cells
in a field of view were calculated from frequency domain FLIM
images, and fluorescence lifetime histograms were obtained.
After Gaussian fitting of the histograms, the average GFP life-
time of K562 cells expressing ALCAM-GFP only was found to
be 2.89 	 0.23 ns and was unaltered upon co-expression of
cytosolic RFP. In contrast, in K562 cells expressing both
ALCAM-GFP and actin-RFP, the average fluorescence lifetime
for GFP was 2.73 	 0.17 ns; this decrease in fluorescence life-
time relative to the control values suggested a physical proxim-
ity betweenALCAMand actin (Fig. 1C). Selective photobleach-
ing of the acceptor (RFP) under the same conditions showed a
complete recovery of theGFP lifetime (2.82	 0.17 ns) (Fig. 1D),
indicating that the decrease in the fluorescence lifetime of
ALCAM-GFP in the presence of actin-RFP could be unambig-
uously attributed to energy transfer between GFP and RFP.
These data clearly demonstrate co-localization of ALCAM and
actin at the nanometer level and motivate the application of
FLIM to further investigate the ALCAM-cytoskeleton interac-
tion at the molecular level.
ALCAM Interacts with Ezrin and Syntenin-1—As depicted in
Fig. 2A, the cytoplasmic tail of ALCAM contains putative ERM
and syntenin-1-binding motifs. To investigate whether these
cytoplasmic linkermolecules are involved in linkingALCAMto
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the actin cytoskeleton, K562 cells with stable expression of
ALCAM-GFP were transiently co-transfected with ezrin-RFP.
Donor fluorescence (ALCAM-GFP) lifetime images were col-
lected (Fig. 2B), and the FLIM data from over 100 cells were
averaged to yield fluorescence lifetime histograms for statistical
analyses (Fig. 2C). The FLIM images and histograms reveal that
the fluorescence lifetime of ALCAM-GFP is decreased in the
presence of ezrin-RFP. Gaussian fitting of the histograms
resulted in average lifetimes of 2.89	 0.23 ns and 2.72	 0.19 in
the absence and presence of ezrin-RFP, respectively, indicating
energy transfer from GFP to RFP and therefore a molecular
interaction between ALCAM and ezrin prior to ligand binding.
Subsequently, cells co-expressing ALCAM-GFP and ezrin-RFP
were allowed to adhere onto glass coverslips previously coated
with CD6-Fc, thus stimulating ALCAM-mediated adhesion.
The corresponding GFP fluorescence lifetimes were collected,
resulting in an average value of 2.64 	 0.18 ns, indicating that
ALCAM-CD6 interactions moderately affect ALCAM-ezrin
interactions. Finally, the K562 cells co-expressing ALCAM-
GFP and ezrin-RFPonCD6-Fc surfaceswere subjected to treat-
mentwith LatA, a powerful actin cytoskeleton disrupting agent.
The resulting GFP fluorescence lifetimes show fully recovered
values of 2.84 	 0.24 ns, demonstrating that ALCAM-ezrin
interactions depend on the integrity of the cortical actin cyto-
skeleton (Fig. 2C). The acceptor photobleaching control further
strengthened these observations, with a recovery from 2.62 	
0.16 to 2.86 	 0.22 ns after RFP photobleaching (Fig. 2D).
Treatment with LatA induces a decrease of ALCAM-ezrin co-
localization and redistributes ezrin from the membrane cortex
to the cytoplasm (Fig. 3). Altogether, these data clearly show
FIGURE 1. Ligand-independent interaction between ALCAM and actin is detected by FRET-FLIM. A, confocal microscopy shows the co-localization
between ALCAMand actin in fixed K562 cells double-transfectedwith ALCAM-GFP (green) and actin-RFP (red). Panel a represents amerged three-dimensional
projection of the ALCAM and actin channels. Scale bar, 5 m. B, representative FLIM images of K562 cells expressing ALCAM-GFP alone, ALCAM-GFP and
cytoplasmic RFP, and ALCAM-GFP and actin-RFP. Horizontal bar indicates a continuous color scale of the GFP lifetime, ranging from 1 to 4 ns. C, lifetime
histogram represents the distribution of average fluorescence lifetime values of GFP molecules recorded from 100 cells per condition. D, fluorescence
lifetimes of ALCAM-GFP co-expressed with actin-RFP were collected from
 6–10 cells (open symbols). Subsequently, the acceptor RFP was photobleached,
and the average GFP fluorescence lifetime was calculated again (filled symbols). a.u., arbitrary units.
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that ALCAM and ezrin pre-assemble into ligand-independent
complexes that are dependent on the intact cortical actin cyto-
skeleton and that are moderately influenced by ALCAM
engagement to its ligand CD6.
Next, we investigated the potential interaction between
ALCAMand syntenin-1. K562 cells stably expressing ALCAM-
GFPwere transiently co-transfected with syntenin-1-mCherry.
The mCherry protein is a variant of RFP that also forms a suit-
able FRET acceptor for GFP. FLIM data of multiple cells were
collected (Fig. 2E), and the average fluorescence lifetime histo-
gram is shown in Fig. 2F. The measurements reveal that the
fluorescence lifetimes of ALCAM-GFP are significantly
decreased in the presence of syntenin-1-mCherry. Gaussian fit-
ting of the histograms resulted in average lifetimes of 2.89 	
0.23 and 2.70	 0.19 ns in the absence andpresence of syntenin-
1-mCherry, respectively. Furthermore, cells co-expressing
ALCAM-GFP and syntenin-1-mCherrywere allowed to adhere
onto glass coverslips coated with CD6-Fc. The GFP fluores-
cence lifetimes were collected, resulting in an average of 2.53	
0.16 ns, suggesting a powerful effect of ALCAM-CD6 extracel-
lular binding on enhancing ALCAM-syntenin-1 intracellular
interactions, in contrast to the modest effect observed for
ALCAM-ezrin interactions. Treatment with LatA leads to a full
recovery of the GFP fluorescence lifetimes to 2.82 	 0.20 ns
(Fig. 2F). An acceptor photobleaching control also reveals a
recovery of GFP fluorescence lifetime from 2.46 	 0.14 to
2.81 	 0.21 ns (Fig. 2G). To exclude that the interactions
observed between ALCAM and ezrin and between ALCAM
and syntenin-1 were cell type-specific, analogous FRET-FLIM
experimentswere performedusing antigen-presenting cells, i.e.
RAWmacrophages (Fig. 4, A and B). These data are similar to
those observed on K562 cells (Fig. 2), although LatA treatment
with the same concentration appears to have only a partial
effect on restoring the lifetime of syntenin-1-GFP on RAW
cells, as compared with the more dramatic effect exhibited in
K562 cells (Fig. 2F). This may be due to the fact that in RAW
macrophages the actin cytoskeleton is not fully disrupted.
These data demonstrate that in both cell types, syntenin-1 is
already present in ligand-independent ALCAM supramolecu-
lar assemblies, but ALCAM binding to its ligand CD6 strongly
enhances the intracellular interaction between ALCAM and
syntenin-1.
To check that our molecules of interest are expressed in pri-
mary monocyte-derived DCs, DCs were stained for ALCAM,
syntenin-1, and ezrin. Fig. 4C shows the co-localization of
FIGURE 2.ALCAM interactswith ezrin and syntenin-1. A, amino acid sequence of ALCAM cytoplasmic tail. The schematic depicts the cell adhesionmolecule
ALCAM at the cellular membrane. The short 32-amino acid cytoplasmic tail of ALCAM contains several positively charged amino acids at the juxtamembrane
position, which constitute the ERM-binding motif, and the KTEA-binding motif, which is a PDZ-binding site, at the C terminus. B, K562 cells expressing
ALCAM-GFP were transfected with ezrin-RFP and allowed to adhere onto uncoated coverslips (panels i and ii) or to coverslips previously coated with CD6-Fc
molecules (panels iii and iv). Cells in panel ivwere treated with 0.2 g/ml LatA for 1 h at 37 °C. After 1 h, cells were subjected to FRET-FLIM analysis. Panels i–iv
areFLIM imagesof cells fromone representativeexperimentoutof at least three.Vertical bar indicates a continuous color scaleof theGFP lifetime, ranging from
1 to 4 ns. C, lifetime histogram represents the distribution of average fluorescence lifetime of GFP molecules recorded from 100 cells per condition. D,
fluorescence lifetimes of ALCAM-GFP co-expressedwith ezrin-RFPwere collected (open symbols). Subsequently, the acceptor RFPwas photobleached, and the
average GFP fluorescence lifetime was calculated again (filled symbols). E, K562 cells expressing ALCAM-GFP were transfected with syntenin-1-mCherry and
allowed to adhere onto uncoated coverslips (panels i and ii) or to coverslips previously coated with CD6-Fc molecules (panels iii and iv). Cells in panel ivwere
allowed to adhere to the CD6-coated substrate and subsequently treated with 0.2 g/ml LatA for 60 min at 37 °C before FRET-FLIM measurements were
performed. Panels i–iv are representative FLIM images of cells from multiple experiments. Vertical bar indicates a continuous color scale of the GFP lifetime,
ranging from 1 to 4 ns. F, lifetime histogram represents the distribution of average fluorescence lifetime of GFP molecules recorded from 100 cells per
condition.G, fluorescence lifetimes of ALCAM-GFP co-expressedwith syntenin-1-mCherrywere collected (open symbols). Subsequently, the acceptormCherry
was photobleached and the average GFP fluorescence lifetime was calculated again (filled symbols). a.u., arbitrary units.
FIGURE 3. Ezrin localizes to ALCAM only in presence of actin. A, confocal microscopy images of K562 cells double-transfected with ALCAM-GFP and
ezrin-RFP showco-localizationofALCAMclusterswith ezrin at the cell cortex (left panels). Cross-sectionof the cells indicated show the co-localizationofALCAM
and ezrin at the cell cortex (right panel). B, after treatment of these cells with the actin-disrupting drug LatA for 30min at 37 °C, co-localization of these ALCAM
clusters is disrupted, and ezrin distribution is predominantly cytoplasmic (left panels). Cross-section of the cells indicated confirms disruption of co-localization
of ALCAM and ezrin and cytoplasmic distribution of ezrin (right panel). C, quantification of co-localization of ezrin with ALCAM (n  15 cells) by Manders’
co-localization coefficient (1 full co-localization and 0 none; ***, p 0.0001) with and without LatA treatment.
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ALCAMand syntenin-1 aswell as ofALCAMand ezrin in small
clusters at the cell membrane.
Altogether, these FRET-FLIM data show that both ezrin and
syntenin-1 interact with ALCAM’s cytoplasmic tail in the
absence of ligand binding. Furthermore, although ALCAM-ez-
rin interaction is only modestly increased by ALCAM binding
to CD6, the extent of ALCAM-syntenin-1 interactions is much
higher upon the establishment of adhesion, suggesting a differ-
ent role for these two proteins within the ALCAM supramo-
lecular complex.
FIGURE 4.ALCAM interactswithezrin and syntenin-1onantigen-presenting cells.A,RAWmacrophageswere co-transfectedwith ezrin-GFP andALCAM-RFPor
RFP. Some of the cells were preincubatedwith 0.2g/ml LatA. The lifetime histogram represents the distribution of average fluorescence lifetime of GFPmolecules
recorded from100 cells in the absence/presence of ALCAM-RFP or RFP. B, RAWmacrophages were co-transfected with syntenin-1-GFP and ALCAM-RFP or RFP.
Some of the cells were preincubated with 0.2 g/ml LatA. The lifetime histogram represents the distribution of average fluorescence lifetime of GFP molecules
recorded from100cells in theabsence/presenceofALCAM-RFPorRFP.a.u.,arbitraryunits.C, immaturemonocyte-derivedDCswere stained forALCAM(green) and
syntenin-1 (red)orALCAM(green) andezrin (red) andanalyzedbyconfocalmicroscopy.Topandthirdrowshowtwoexamplecellswith foreachazoom-in (dotted lines)
in the rows below. Clusters of co-localized ALCAMand syntenin-1 aswell as ALCAMand ezrin are visible at the cell membrane. Scale bar, 5m.
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Syntenin-1 and Ezrin Co-immunoprecipitate with ALCAM—
To confirm the interactions of ALCAM with syntenin-1 and
ALCAM with ezrin as determined by FLIM, we performed co-
immunoprecipitation (co-IP) assays of ALCAM. Syntenin-1
and ezrin were co-immunoprecipitated with anti-ALCAM
beads from the PNS of K562 cells stably expressing ALCAM
(K562-ALCAM) or PNS of control K562 cells that do not
express endogenous ALCAM. We could detect endogenous
syntenin-1 by WB; however, the syntenin-1 bands overlapped
with unspecific bands probably from the light chain of our
immunoprecipitation antibody (data not shown). To circum-
vent this problem, K562-ALCAM cells were transfected with
syntenin-1-GFP. Fig. 5A shows that syntenin-1-GFP co-IPs
with ALCAM, as detected by a specific antibody recognizing
syntenin-1, as well as by an antibody directed against GFP. In
addition to syntenin-1, enrichment of ALCAM by a specific
immunoprecipitation also showed co-IP of endogenous ezrin,
confirming the molecular interaction of ALCAM and ezrin
(Fig. 5B). Neither syntenin-1-GFP nor ezrin bands could
detected in our control immunoprecipitation on non-ALCAM-
transfected K562 cells, confirming the specific co-IP of syn-
tenin-1-GFP and ezrinwithALCAM.Thus, taken together, our
co-IP and FLIM experiments demonstrate a direct interaction
between ALCAM and syntenin-1 as well as ALCAM and ezrin.
Syntenin-1 Interacts with KTEA Sequence of ALCAM—To
determine whether syntenin-1 and ezrin are recruited within
the same supramolecular assembly that regulates ALCAM-me-
diated adhesion, we investigated the molecular interaction
between these two proteins in the absence and the presence of
ALCAM. The K562 cells (mock) as well as K562 cells stably
expressing ALCAMwild type (K562-ALCAM-WT) were tran-
siently co-transfected with syntenin-1-GFP and ezrin-RFP, and
changes in GFP lifetime were detected by FRET-FLIM analysis.
On bare K562 cells, similar GFP fluorescence lifetime values
were determined in the absence and in the presence of ezrin-
RFP, indicating that in the absence of ALCAM-mediated adhe-
sion, ezrin and syntenin-1 do not interact (Fig. 6A). On the
contrary, when syntenin-1-GFP and ezrin-RFP were co-trans-
fected in K562-ALCAM-WT cells, a modest decrease in GFP
fluorescence lifetime from 2.74 	 0.16 to 2.61 	 0.11 ns was
observed (Fig. 6B). Furthermore, when the K562-ALCAM-WT
cells co-expressing syntenin-1-GFP and ezrin-RFP were prein-
cubated with LatA, the GFP fluorescence lifetime value was
found to be the same as that observed in K562 cells lacking
ALCAMexpression (Fig. 6B). Finally, both ezrin and syntenin-1
have been confirmed to interact with actin by FLIM measure-
ments (Fig. 6, D and E). This finding indicates that both
ALCAM and an intact actin cytoskeleton are specifically
required to form these ligand-independent supramolecular
complexes containing ezrin and syntenin-1.
Next, we used K562 cells stably expressing the ALCAM-
Thr mutant, where the threonine residues at positions 556
and 581 (the latter belonging to the KTEA sequence, the puta-
tive binding motif for syntenin-1 (see Fig. 2A) (46), were
mutated to alanine (19). In particular, the T581A mutation is
thought to disrupt the KTEA motif and likely to impair the
binding of syntenin-1 toALCAM.Accordingly, when syntenin-
1-GFP was transiently co-transfected with ezrin-RFP in K562
cells stably expressing the ALCAM-Thr mutant, no variation
in the GFP lifetime values was observed (Fig. 6C), indicating
FIGURE 5. Ezrin and syntenin-1 co-immunoprecipitate with ALCAM. A, ALCAM (expected size105 kDa) was detected by mouse anti-ALCAM (AZN-L50)
specifically in the PNS of K562-ALCAM cells transfected with syntenin-1-GFP and was absent in the PNS of control K562 cells (left panel, 1st and 2nd lanes).
ALCAMwas enriched from the PNS of K562-ALCAM syntenin-1-GFP cells by immunoprecipitation (IP) using anti-ALCAMbeads (left panel, 3rd and 4th lanes).
Syntenin-1-GFP (expected size60 kDa) was co-immunoprecipitated with ALCAM only for K562-ALCAM syntenin-1-GFP cells (middle panel). Re-immuno-
blotting the anti-ALCAM immunoblot (IB) with anti-GFP shows that the syntenin-1-GFP bands are specific for syntenin-1 as well as for GFP (right panel). B,
ALCAMwas enriched from the PNS of K562-ALCAM cells by immunoprecipitation using anti-ALCAM beads (left panel). Endogenous ezrin (expected size80
kDa) was co-immunoprecipitated with ALCAM only for K562-ALCAM cells (right panel). Endogenous ezrin is also present in the PNS of K562 cells but is not
co-immunoprecipitated with ALCAM. Double ezrin bands in PNS are typical for the antibody used.
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that the cytoplasmic tail of ALCAM is essential to recruit syn-
tenin-1 and facilitate its interaction with ezrin. Moreover,
FLIM experiments using the FRET pair mTurquoise2 (mTQ2)
and Venus (39) on K562 cells transfected with ALCAM-Thr-
mTQ2and syntenin-1-Venus confirmed that syntenin-1 canno
longer bind ALCAM’s cytoplasmic tail in contrast to ALCAM-
WT-mTQ2 (Fig. 6F). These observations were further sup-
ported by the dramatic decrease of co-localization between
FIGURE 6. ALCAM specifically recruits ezrin and syntenin-1 to a ligand-independent supramolecular assembly. Fluorescence lifetime histograms of
syntenin-1-GFP co-transfectedwith or without ezrin-RFPwere collected from K562 cells (100 cells per condition) with no endogenous expression of ALCAM
(A), from K562-ALCAM-WT cells (B), or from K562-ALCAM-Thr cells (C). B also shows the lifetime histogram of syntenin-1-GFP co-transfected with ezrin-RFP,
before and after treatment with 0.2 g/ml LatA. D, fluorescence lifetime of K562 cells transfected with ezrin-GFP alone and in combination with actin-RFP (E)
or with syntenin-1-GFP alone and in combinationwith actin-RFP clearly indicatemolecular scale interactions. F, lifetime histograms fromK562 cells expressing
ALCAM-WT-mTQ2 or ALCAM-Thr-mTQ2 co-transfected with syntenin-1-Venus and allowed to adhere onto poly-L-lysine-coated glass bottom dishes for 1 h.
The lifetime histogram represents the distribution of averaged fluorescence lifetime of mTQ2molecules recorded from60 cells per condition. a.u., arbitrary
units.
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ALCAM-Thr and actin, or syntenin-1, but not ezrin, as com-
pared with the ALCAM-WT, determined after inducing aggre-
gation of the ALCAMmolecules at the cell surface using a spe-
cific anti-ALCAM mAb and staining for the cytoskeletal
components after fixation and permeabilization of the cells
(Fig. 7,A and B). The presence of a GFP fused to the C terminus
of ALCAM did not affect the degree of co-localization with
actin, syntenin-1, or ezrin (Fig. 7B). In addition, replacing the
intracellular and transmembrane domains of ALCAMby a GPI
anchor showed that ALCAM cannot interact with any of the
intracellular molecules actin, syntenin-1, or ezrin (Fig. 7B).
Single-cell Force Spectroscopy Shows Strengthening by Actin
Binding—To determine whether syntenin-1 plays a role in
ALCAM-mediated adhesion, AFM-based SCFS studies were
performed. Similar to earlier studies (26), single K562 cells
either expressing ALCAM-WT or the ALCAM-Thr mutant
were attached to a tipless AFM cantilever by means of ConA-
mediated linkages. Subsequently, cell adhesion forces were
measured by bringing the ALCAM-expressing K562 cells
shortly into contact with CD6-coated substrates before pulling
the adhering cells from the substrate (Fig. 8A). Repetitive adhe-
sion-detachment cycles, as plotted in so-called force-distance
(F-D) curves, give information on the strength of the adhesion
(Fig. 8B). The maximum force (Fmax) needed to detach the cell
from the substrate, derived from the distance between themax-
imum and baseline of the detachment curve, was taken as a
measure for overall cell adhesion (26, 44). After the initial
acquisition of F-D curves, K562-ALCAM-WT as well as K562-
ALCAM-Thr cells were blocked in situwith the anti-ALCAM
mAb AZN-L50 and re-examined under identical experimental
conditions (Fig. 8C). AZN-L50 specifically blocked 45 	 6 or
66	 7% for ALCAM-WT and ALCAM-Thr, respectively, of
the total adhesion indicating that the interactions probed are
predominantly ALCAM-CD6-mediated (Fig. 8D). Comparison
of the Fmax needed to detach the ALCAM-WT and ALCAM-
Thr cells after a 2-s interaction with CD6 showed that signif-
icantlymore force (1.45	 0.37 versus 0.76	 0.35 nN) is needed
to detach the ALCAM-WT than for the ALCAM-Thr-ex-
FIGURE 7. Co-localization of ALCAM with actin, syntenin-1, and ezrin on K562 cells expressing different ALCAM constructs. A, immunofluorescent
labeling of actin, syntenin-1, and ezrin onK562-ALCAM-WTandK562-ALCAM-Thr cells analyzedby confocalmicroscopy. Cellswere fixed, permeabilized, and
co-labeled with antibodies against ALCAM and with either phalloidin to stain actin or with antibodies against syntenin-1 or ezrin. Scale bars, 5 m. Immuno-
fluorescence samples for K562-ALCAM-GFPandK562-ALCAM-GPI arenot shown.B,quantificationof the co-localizationbetweenALCAMandactin, syntenin-1,
or ezrin for ALCAM-WT, ALCAM-Thr, ALCAM-GFP, and ALCAM-GPI. The GFP tag does not affect ALCAM interactionswith cytoskeletal components. When the
transmembrane and intracelullar domain of ALCAM are replaced by a GPI anchor, ALCAM cannot interact with any of the cytoskeletal components. Quantifi-
cation of the co-localization between ALCAM (WT versus Thr, WT versus GFP, and WT versus GPI) and actin, syntenin-1, or ezrin was made by calculating the
Manders’ co-localization coefficient (1 full co-localization and0no co-localization).p valueswere calculatedwith theMann-Whitney statistical test and are
indicated in the plot; ***, p 0.0001; n.s., not significant.
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FIGURE 8. Syntenin-1 recruitment to the supramolecular assembly stabilizes ALCAM adhesion. A, schematic overview of single-cell force spectroscopy
measurements. The tipless cantileverwith anadheredK562-ALCAM-WTorK562-ALCAM-Thr cellwas approached towarda surface coatedwithCD6-Fc.When
a contact force of 1 nN was reached, the cell was allowed to adhere for 2 s to the substrate. Then, the cell-functionalized cantilever was retracted from the
substrate thereby disrupting the adhesion. When the cell was completely detached, the probing cycle was repeated. B, example of a force-distance
curve showing the approach and retraction curve and themaximumdetachment force (Fmax), which is the distance between themaximum force and the
baseline in the retraction curve. C, three representative F-D curves displaying the unbinding of K562-ALCAM-WT and K562-ALCAM-Thr cells after a 2-s
contact with the CD6-Fc-coated substrate. Furthermore, three F-D curves are shown after a specificity block with 10 g/ml of the anti-ALCAM antibody
AZN-L50 for 30min at 37 °C in both the case of K562-ALCAM-WT and K562-ALCAM-Thr cells.D, box plot showing the specific block (n 3 independent
experiments) of the normalized Fmax of ALCAM-CD6-mediated interactions by the mAb AZN-L50. E, scatterplot comparison of Fmax needed to detach a
K562-ALCAM-WT or K562-ALCAM-Thr cell (n 7) from a CD6-Fc-coated substrate. Data presented are of n 24 K562-ALCAM-WT and K562-ALCAM-
Thrmeasurements, each consisting of n 20 F-D curves. p valueswere calculatedwith theMann-Whitney statistical test and are indicated in the figure.
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pressing cells (Fig. 8E). This suggests that the specific additional
recruitment of syntenin-1 to the cytoplasmic tail of ALCAM
strengthens and stabilizes binding to the ligand CD6.
DISCUSSION
This study combines FRET-FLIM measurements with sin-
gle-cell force spectroscopy and co-IPs to demonstrate that in
resting cells in the absence of active cell adhesion the trans-
membrane proteinALCAM is pre-organized in a supramolecu-
lar complex consisting of syntenin-1, ezrin, and actin. Binding
of ALCAM to its ligand CD6 further strengthens and augments
these interactions (Fig. 9). Finally, binding of syntenin-1 to the
ALCAM cytoplasmic tail appears to be crucial to maintain
the integrity of the complex and to mediate strong adhesion to
the ligandCD6. Because the heterotypic ALCAM-CD6 interac-
tion has been shown to play an important role in the formation
and strengthening of the immunological synapse, our study
provides for the first time insights into the molecular players in
a strong adhesive complex formed at theDC side of the synapse
that could contribute to stabilize the DC-T cell contact.
Although interactions betweenALCAMand actin have already
been demonstrated (18, 19, 26), nothing was known about the
intracellular partners physically mediating the interaction
between the actin cytoskeleton and the cytoplasmic tail of
ALCAM. Interactions with ezrin most likely represent the
molecular link between ALCAM and the cytoskeleton. Co-im-
munoprecipitation shows that ezrin binds to ALCAM. The
capacity of ezrin to bind to PDZ-containing proteins, such as
EBP50 (47), opens the possibility that binding toALCAMcould
occur via syntenin-1 or a yet unknown partner. A known cyto-
plasmic interactor of ALCAM is protein kinase C (PKC),
which our laboratory previously demonstrated to play a role in
cytoskeleton-dependent avidity modulation of homo- and het-
erotypic ALCAM-mediated adhesion (19). However, the cyto-
plasmic tail of ALCAM is not a direct target for PKC, because
it is not phosphorylated after PKC activation, and it does not
contain conserved PKC phosphorylation motifs (19). Because
PKCcan influence ERMprotein activities, both by altering their
conformation and by determining the binding capacity of their
interaction partners (48), it is tempting to speculate that ezrin
could be the direct target for PKC at these ALCAM supramo-
lecular complexes. Recent work fromHwangbo et al. (49) dem-
onstrated that syntenin-1 alsomediates adhesion-induced acti-
vation of PKC in human breast cancer and melanoma cells,
suggesting the existence of a possible interplay between PKC,
syntenin-1, and ezrin at the ALCAM supramolecular complex.
Furthermore, a spatiotemporal regulatory role for syntenin-1
in actin remodeling has also been documented in CD4 T cells
during HIV-1 binding and entry (50). By single-cell force spec-
troscopy, we have here demonstrated that the interaction with
syntenin-1 is strictly dependent onThr residues in the cytoplas-
mic tail of ALCAM. Previous work from our laboratory showed
no difference between cells expressing ALCAM wild type and
cells expressing the ALCAM-Thr mutant in the ability to
attach to ALCAM-coated plates (19), thus in apparent contrast
to the single-cell force spectroscopy measurements reported
here. However, this discrepancy can be reconciled by the fact
that, with respect to a static plate adhesion assay, single-cell
force spectroscopy better mimics the dynamic interactions
occurring between cells and ligand (51, 52) and is therefore
better suited to pinpoint subtle differences in adhesion strength
of short lived interactions under force/stress. Recognition of
C-terminal motifs appears to be the dominant mode of PDZ-
ligand interaction; however, binding to non-C-terminal “inter-
nal”motifs has also been reported in the literature (53, 54). This
FIGURE 9.Model of the supramolecular complex formedduringALCAM-CD6-mediated adhesion.WhenALCAMbinds CD6, a supramolecular complex is
formed with the adaptor proteins ezrin and syntenin-1 coupling the cytoplasmic tail of ALCAM to actin. Syntenin-1 binds the PDZ-binding motif at the C
terminus of the cytoplasmic tail and tightens the bonds by coupling ALCAM to the actin cortex. Ezrin also connects some of the ALCAM molecules at a
juxtamembrane site to actin. Upon binding of ALCAM to its ligand CD6, the complex is tightened and syntenin-1 as well as ezrin could be phosphorylated
leading to outside-in signaling and ultimate cellular responses. PM, plasma membrane.
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could explain why the GFP tag fused at the C terminus of
ALCAM did not affect the interaction of the PDZ-binding
motif in the ALCAM tail with syntenin-1.
Another player that might have a role in regulating the inter-
action of ALCAMwith cytoskeletal component is the tetraspa-
nin CD9 that was reported to directly interact with ALCAM at
the cell surface of T cells, thereby enhancing ALCAM function
by augmented clustering of ALCAMmolecules and up-regula-
tion of ALCAM surface expression (55). In fact, CD9 has been
shown to be part of a tetraspanin web that is directly linked to
ERM proteins (56) and to modulate the composition of adhe-
sive complexes influencing the presence of integrins, actin, and
actin-binding proteins at sites of cell adhesion and matrix
assembly (57). CD9 could therefore play a yet unrecognized role
on organizing the ALCAM supramolecular assembly.
This study is one of the few addressing the players of the
immunological synapse at the DC side. We confirmed that
human DCs express ALCAM as well as syntenin-1 and ezrin,
which corresponds with RNA expression data (58). In fact,
although an abundance of information is available about the
receptors and their dynamics at the surface of the T cell, includ-
ing the involvement of syntenin-1 in T cell polarization (59),
very little is known about the biochemical signals transduced
into the interacting DC. In fact, the DC side of the immunolog-
ical synapse has been reported to have an anti-apoptotic func-
tion to keep the DC alive and fit as long as possible to increase
the chance of effective encounters with T cells (60). Moreover,
Al-Alwan et al. (61, 62) demonstrated that the DC cytoskeleton
does not play a passive role in the formation of the immunolog-
ical synapse but is rather actively polarized upon MHC class II
ligation and critical for proper T cell activation. The engage-
ment of ALCAM with CD6 on the T cells could therefore con-
tribute to this process by allowing the formation of a stable
nucleation site for further actin polymerization to strengthen
the cell-cell interaction. In addition, in T cells ezrin has been
shown to be a negative regulator of death receptor-induced
apoptosis (63). The enrichment of ezrin in the ALCAM supra-
molecular assembly at the DC side could provide another sur-
vival signal to the DCs.
This study contributes to increasing our understanding of
the DC-associated molecular players involved in the mechani-
cal strengthening of the contact with T cells, which might pro-
vide novel insights into regulatorymechanisms of DC function.
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